Official Title
The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring
Brief Summary

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.

Completed
COVID-19

Device: C3+ Holter Monitor

ECG monitoring

Eligibility Criteria

Inclusion Criteria:

- All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a
laboratory confirmed diagnosis of COVID-19 > 18 years of age.

Exclusion Criteria:

- Persons not able to cooperate

- Persons unable to understand and sign "informed consent"

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Denmark
Locations

Department of Cardiology, Herlev & Gentofte Hospital
Copenhagen, Hellerup, Denmark

Herlev and Gentofte Hospital
NCT Number
MeSH Terms
COVID-19